b-Sheet aggregates and amyloid fibrils rising from conformational changes of proteins are observed in several pathological human conditions. These structures are organized in b-strands that can reciprocally interact by hydrophobic and p–p interactions. The amyloid aggregates can give rise to pathological conditions through complex biochemical mechanisms whose physico-chemical nature has been understood in recent times. This review focuses on the various classes of natural and synthetic small molecules able to act against b-amyloid fibrillogenesis and toxicity that may represent new pharmacological tools in Alzheimer’s diseases. Some peptides, named ‘b-sheet breaker peptides’, are able to hamper amyloid aggregation and fibrillogenesis by interfering with and destabilizing the non native b-sheet structures. Other natural compounds, like polyphenols or indolic molecules such as melatonin, can interfere with b-amyloid peptide pathogenicity by inhibiting aggregation and counteracting oxidative stress that is a key hallmark in Alzheimer’s disease.

b-Sheet interfering molecules acting against b-amyloid aggregation and fibrillogenesis / Francioso, Antonio; Punzi, Pasqualina; Boffi, Alberto; Lori, Clorinda; Martire, Sara; Giordano, CESARE GIOVANNI; D'Erme, Maria; Mosca, Luciana. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 1464-3391. - STAMPA. - 23:(2015), pp. 1671-1683. [10.1016/j.bmc.2015.02.041]

b-Sheet interfering molecules acting against b-amyloid aggregation and fibrillogenesis

FRANCIOSO, ANTONIO;PUNZI, PASQUALINA;BOFFI, Alberto;LORI, CLORINDA;MARTIRE, SARA;GIORDANO, CESARE GIOVANNI;D'ERME, Maria;MOSCA, Luciana
2015

Abstract

b-Sheet aggregates and amyloid fibrils rising from conformational changes of proteins are observed in several pathological human conditions. These structures are organized in b-strands that can reciprocally interact by hydrophobic and p–p interactions. The amyloid aggregates can give rise to pathological conditions through complex biochemical mechanisms whose physico-chemical nature has been understood in recent times. This review focuses on the various classes of natural and synthetic small molecules able to act against b-amyloid fibrillogenesis and toxicity that may represent new pharmacological tools in Alzheimer’s diseases. Some peptides, named ‘b-sheet breaker peptides’, are able to hamper amyloid aggregation and fibrillogenesis by interfering with and destabilizing the non native b-sheet structures. Other natural compounds, like polyphenols or indolic molecules such as melatonin, can interfere with b-amyloid peptide pathogenicity by inhibiting aggregation and counteracting oxidative stress that is a key hallmark in Alzheimer’s disease.
2015
Alzheimer’s diseaseAmyloid fibrillogenesisb-Sheet aggregatesb-Sheet breaker peptidesNatural compounds
01 Pubblicazione su rivista::01a Articolo in rivista
b-Sheet interfering molecules acting against b-amyloid aggregation and fibrillogenesis / Francioso, Antonio; Punzi, Pasqualina; Boffi, Alberto; Lori, Clorinda; Martire, Sara; Giordano, CESARE GIOVANNI; D'Erme, Maria; Mosca, Luciana. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 1464-3391. - STAMPA. - 23:(2015), pp. 1671-1683. [10.1016/j.bmc.2015.02.041]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/783107
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 61
social impact